GL MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GL MEDICAL
Largest movements
- Intangible fixed assets +€171,000
new in 2025: €171,000
- Cash +€21,353
up €21,353 (+712%), from €3,000 to €24,353
mainly Trade debts (+€146,441) and Other debts (+€37,803)
- Tangible fixed assets +€3,779
new in 2025: €3,779
of which Furniture and vehicles: +€3,530
- Trade debts +€146,441
up €146,441 (+4,869%), from €3,008 to €149,448
- Other debts +€37,803
new in 2025: €37,803
- Profit (loss) carried forward +€11,331
up €11,331, from -€3,008 to €8,323
- Tax, wage and social debts +€2,532
new in 2025: €2,532
- Gross operating margin +€27,582
up €27,582, from -€3,008 to €24,575
- Depreciation +€9,955
new in 2025: €9,955
- Taxes +€2,532
new in 2025: €2,532
- Other operating charges +€575
new in 2025: €575
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,000 | €201,106 | +€198,106 | +6,604% |
| Fixed assets | 21/28 | - | €174,779 | +€174,779 | |
| Intangible fixed assets | 21 | - | €171,000 | +€171,000 | |
| Tangible fixed assets | 22/27 | - | €3,779 | +€3,779 | |
| Plant, machinery and equipment | 23 | - | €249 | +€249 | |
| Furniture and vehicles | 24 | - | €3,530 | +€3,530 | |
| Current assets | 29/58 | €3,000 | €26,328 | +€23,328 | +778% |
| Cash at bank and in hand | 54/58 | €3,000 | €24,353 | +€21,353 | +712% |
| Deferred charges and accrued income | 490/1 | - | €1,974 | +€1,974 | |
| Total equity and liabilities | 10/49 | €3,000 | €201,106 | +€198,106 | +6,604% |
| Equity | 10/15 | -€8 | €11,323 | +€11,331 | |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€3,008 | €8,323 | +€11,331 | |
| Amounts payable | 17/49 | €3,008 | €189,783 | +€186,776 | +6,210% |
| Amounts payable within one year | 42/48 | €3,008 | €189,783 | +€186,776 | +6,210% |
| Trade debts | 44 | €3,008 | €149,448 | +€146,441 | +4,869% |
| Suppliers | 440/4 | €3,008 | €149,448 | +€146,441 | +4,869% |
| Taxes, remuneration and social security | 45 | - | €2,532 | +€2,532 | |
| Taxes | 450/3 | - | €2,532 | +€2,532 | |
| Other amounts payable | 47/48 | - | €37,803 | +€37,803 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €9,955 | +€9,955 | |
| Other operating charges | 640/8 | - | €575 | +€575 | |
| Gross operating margin | 9900 | -€3,008 | €24,575 | +€27,582 | |
| Operating profit (loss) | 9901 | -€3,008 | €14,045 | +€17,053 | |
| Financial charges | 65/66B | - | €183 | +€183 | |
| Recurring financial charges | 65 | - | €183 | +€183 | |
| Profit (loss) for the period before taxes | 9903 | -€3,008 | €13,862 | +€16,870 | |
| Income taxes | 67/77 | - | €2,532 | +€2,532 | |
| Profit (loss) for the period | 9904 | -€3,008 | €11,331 | +€14,338 | |
| Profit (loss) for the period to be appropriated | 9905 | -€3,008 | €11,331 | +€14,338 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.